He conducted his postdoctoral research at Brigham and Women's Hospital / Harvard Medical School, where he researched the role of the Wnt signaling pathway in mouse models of kidney disease, and was part of a team that discovered
a stem cell subtype responsible for solid organ fibrosis.
Not exact matches
The physician scientists sought to identify glioblastoma
subtype - specific cancer
stem cells.
This study shows that the mesenchymal
subtype is the most aggressive
subtype, that it has the poorest prognosis among affected patients, and that cancer
stem cells isolated from the mesenchymal
subtype have significantly higher levels of the enzyme ALDH1A3 compared with the proneural
subtype.
«Certain
subtypes of leukemia are very hard to treat and typically children with these
subtypes have poor prognosis,» said Dr. Dinesh Rao, the study's senior author and a member of the UCLA Eli and Edythe Broad Center of Regenerative Medicine and
Stem Cell Research.
«Our study suggests that if a cancer - causing mutation occurs in the neural
stem cell population in the SVZ, it gives rise to the proneural or the neural glioblastoma
subtype.
«There is growing evidence that breast cancer consists of different
subtypes of
cells including non-cancer
stem cells and cancer
stem cells,» said Ince, who is also associate professor of pathology at the University of Miami Miller School of Medicine.
«Areas of glioblastoma tumors correlate with separate
subtypes of glioma
stem cells.»
Combinatorial analysis of developmental cues efficiently converts human pluripotent
stem cells into multiple neuronal
subtypes.
In culture, neural
stem cells (NSCs) can readily differentiate into neuronal and glial
subtypes, but their ability to differentiate into region - specific neuronal
cell types is limited.
Neuregulin / ErbB Signaling Regulates Cardiac
Subtype Specification in Differentiating Human Embryonic
Stem Cells.
A common misconception about the research field is that a tumor
stem cell is actually a
subtype of
stem cell and that hence, cancer derives from
stem cells.
Future therapies will have to be based on strategies that act by reducing or increasing the number or activity of specific
subtypes of pre - and postsynaptic receptors, transporters, and ion channels, or other membrane molecules at the synapse, and by strategies that exploit the new possibilities offered by
stem cell technology and targeted repair.
The signatures of the breast
stem cells in the fetus were stunningly similar to the
stem - like
cells found in aggressive breast cancers, including a significant fraction of a virulent cancer
subtype known as «triple - negative.»